UK markets closed
NIKKEI 225
38,385.73 +29.67 (+0.08%) HANG SENG
19,073.71 -41.35 (-0.22%) CRUDE OIL
78.75 +0.73 (+0.94%) GOLD FUTURES
2,392.30 +32.40 (+1.37%) DOW
39,837.23 +279.12 (+0.71%) Bitcoin GBP
51,781.00 +3,365.16 (+6.95%)
BIIB May 2024 220.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 01:13PM EDT. Market open.
| Previous close | 4.77 |
| Open | 10.12 |
| Bid | 12.40 |
| Ask | 20.60 |
| Strike | 220.00 |
| Expiry date | 2024-05-17 |
| Day's range | 10.12 - 15.70 |
| Contract range | N/A |
| Volume | |
| Open interest | 712 |
ZacksBiogen (BIIB) Partner Begins Filing for Leqembi SC Autoinjector
Biogen (BIIB) and Eisai start the rolling submission of a biologics license application to the FDA for Leqembi subcutaneous autoinjector as a weekly maintenance dosing regimen for early Alzheimer's disease.
Investor's Business DailyIs Eli Lilly Stock A Buy Or A Sell With Key Alzheimer's Meeting Looming?
Eli Lilly stock broke out and then retreated into sell-zone territory. With shares on the rise again, is LLY stock a buy?
Investor's Business DailyBiogen Stock Continues Its 20% Sprint On A Twist In Alzheimer's Treatment
Biogen stock jumped early Wednesday after the FDA gave its Eisai-partnered Alzheimer's treatment a fast track designation.
© 2024 Yahoo. All rights reserved.